Vision-based Ultrasonic Robot Autonomous Scanning Research
1 other identifier
observational
800
1 country
1
Brief Summary
MGIR3-US is a remote scanning robot which can perform ultrasound exam. The aim of the study is to evaluate the feasibility and the application of MGIR3-US.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 29, 2021
CompletedStudy Start
First participant enrolled
August 31, 2021
CompletedFirst Posted
Study publicly available on registry
September 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedSeptember 2, 2021
September 1, 2021
3 years
August 29, 2021
September 1, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The degree of satisfaction in participants
The degree of satisfaction in participants
from 2021.08 to 2024.08
Secondary Outcomes (2)
The degree of satisfaction in doctors
from 2021.08 to 2024.08
the lesion inspection rate
from 2021.08 to 2024.08
Study Arms (2)
MGIR3-US group
using MGIR3-US to do ultrasonic examinations.
control group
using conventional B-mode ultrasound to do ultrasonic examinations.
Interventions
MGIR3-US is an remote scanning robot which can do ultrasonic examinations.
Eligibility Criteria
Volunteers are encouraged in the study.
You may qualify if:
- patients who agree using MGIR3 to do ultrasonic examinations
- age from 18 to 65
You may not qualify if:
- Patients who has trauma on the inspection site or on the body surface
- Pregnant patients.
- Patients who are afraid of MGIR3-US
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rongqin Zhenglead
Study Sites (1)
Third Affiliated Hospital of Sun Yat-Sen University
Guangzhou, Guangdong, 510680, China
Study Officials
- PRINCIPAL INVESTIGATOR
Jie Ren, doctor
the third affiated hosptial of Sun Yat-sun University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professors
Study Record Dates
First Submitted
August 29, 2021
First Posted
September 2, 2021
Study Start
August 31, 2021
Primary Completion
August 31, 2024
Study Completion (Estimated)
August 31, 2026
Last Updated
September 2, 2021
Record last verified: 2021-09